Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis

Allogeneic hematopoietic cell transplantation (allo-HCT) remains the only curative treatment for myelofibrosis. However, the optimal conditioning regimen either with reduced-intensity conditioning (RIC) or myeloablative conditioning (MAC) is not well known. Using the Center for International Blood a...

Descripción completa

Detalles Bibliográficos
Autores principales: Murthy, Guru Subramanian Guru, Kim, Soyoung, Estrada-Merly, Noel, Abid, Muhammad Bilal, Aljurf, Mahmoud, Assal, Amer, Badar, Talha, Badawy, Sherif M., Ballen, Karen, Beitinjaneh, Amer, Cerny, Jan, Chhabra, Saurabh, DeFilipp, Zachariah, Dholaria, Bhagirathbhai, Perez, Miguel Angel Diaz, Farhan, Shatha, Freytes, Cesar O., Gale, Robert Peter, Ganguly, Siddhartha, Gupta, Vikas, Grunwald, Michael R., Hamad, Nada, Hildebrandt, Gerhard C., Inamoto, Yoshihiro, Jain, Tania, Jamy, Omer, Juckett, Mark, Kalaycio, Matt, Krem, Maxwell M., Lazarus, Hillard M, Litzow, Mark, Munker, Reinhold, Murthy, Hemant S., Nathan, Sunita, Nishihori, Taiga, Ortí, Guillermo, Patel, Sagar S., van der Poel, Marjolein, Rizzieri, David A, Savani, Bipin N, Seo, Sachiko, Solh, Melhem, Verdonck, Leo F., Wirk, Baldeep, Yared, Jean A., Nakamura, Ryotaro, Oran, Betul, Scott, Bart, Saber, Wael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Article - Myeloproliferative Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316233/
https://www.ncbi.nlm.nih.gov/pubmed/36779595
http://dx.doi.org/10.3324/haematol.2022.281958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316233/
https://www.ncbi.nlm.nih.gov/pubmed/36779595
http://dx.doi.org/10.3324/haematol.2022.281958

Ejemplares similares